$2,099.00
Canada
3rd Party Tested
Targets GLP-1, GIP, and glucagon pathways simultaneously.
Studied for effects on appetite and caloric utilization.
Explored for impact on glucose and lipid metabolism.
Retatrutide has been investigated in recent studies as part of a new class of multi-agonist peptides designed to address complex metabolic systems. Research has examined its effects on weight regulation, insulin sensitivity, and energy expenditure.
Findings suggest that simultaneous activation of GLP-1, GIP, and glucagon receptors may produce synergistic effects across metabolic pathways, including appetite control and fat metabolism.
While research is ongoing, this compound represents a significant shift toward multi-pathway metabolic investigation rather than single-receptor targeting.
FemmeBioLabs presents these compounds within the context of available research — with a focus on accuracy, not exaggeration.
500mg
NAD+ studied for cellular energy production and mitochondrial function.
$1,799.00
100 mg
GHK-Cu 100mg copper peptide for research on collagen synthesis, skin regeneration, and antioxidant activity. High purity. Laboratory use only.
$1,999.00